Dreamfold

Dreamfold is transforming drug discovery by applying generative machine learning to explore the protein universe and unlock new treatments.

Dreamfold is transforming drug discovery by applying generative machine learning to explore the protein universe and unlock new treatments.
Artificial Intelligence
Milestones
Investment year
Investment stage
Investment status
Deal team
Tom Henriksson
Dreamfold is transforming drug discovery by applying generative machine learning to explore the protein universe and unlock new treatments.

Dreamfold is pioneering generative machine learning techniques to navigate the vast landscape of proteins, with the goal of discovering breakthrough medicines. Their work lies at the intersection of machine learning, molecular simulation, and synthetic biology. Founded by researchers from Yoshua Bengio’s lab alongside Michael Bronstein, a leading AI professor at the University of Oxford, Dreamfold is driven by a mission to bring hope to millions of patients who currently have no cure.

News highlights

All news
10
min read

The state of agentic AI in 2025: what’s working, what isn’t, and what’s next

At the start of the year, “2025: The Year of Agents” sounded like headline bait. Eight months in, it feels like an understatement. Sam Altman said agents would “join the workforce” in 2025. Satya Nadella expects them to replace segments of knowledge work. Marc Benioff wants Salesforce to be the “#1 provider of digital labour.” That’s not future tense anymore - today, agents are moving tickets, shipping code, and digesting documents.
9
min read

What we’ve learned from the front lines of AI-enabled services

Last November, we laid out a vision for AI-native services: businesses rebuilt from the ground up to combine the margins of software with the resilience and depth of services markets. Since then, we have taken dozens of first meetings, explored more than 15 verticals, backed our first deals, and sharpened our thesis along the way.
7
min read

Enterprise automation market industry update: automation after GenAI

At OpenOcean, we’ve long believed in automation software’s potential. It’s been a core theme in our investment focus for years, giving us early and continued exposure to exciting developments in the field.
Tom Henriksson
Tom Henriksson
General Partner
Tom Henriksson
Tom Henriksson
General Partner
Artificial Intelligence
Artificial Intelligence